Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NextTrip, Inc.
Report date January 28, 2020 · Filed February 26, 2020
Section 16 reporting ended · disclosed 2020-02-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series E Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.03 | Direct | 16.67 |
Reported balance
After 2020-01-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-28 · Grant · Acquired 16.67 · Balance 16.67 F1: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. F2: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1. |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.13 · Expires 2025-07-28 | Direct | 24,272 |
Reported balance
After 2020-01-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-01-28 · Grant · Acquired 24,272 · Balance 24,272 F1: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.
F2: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2020 Filed Feb 26, 2020 23:05 UTC | NextTrip, Inc. SGLB · Entity 7630 | GrantWarrants to Purchase Common Stock · Derivative | 24,272 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001493152-20-003020 · ownership.xml · derivative · entry 2 Garofalo Frank J · CIK 0001698160 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,272 Underlying: Common Stock · 24,272 shares Expires 2025-07-28 F1 · price: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. Read SEC document |
| January 28, 2020 Filed Feb 26, 2020 23:05 UTC | NextTrip, Inc. SGLB · Entity 7630 | GrantSeries E Preferred Stock · Derivative | 16.67 | $1,500.00 Strike: $1.03 | $25,005.00 |
DisclosureSEC source: 0001493152-20-003020 · ownership.xml · derivative · entry 1 Garofalo Frank J · CIK 0001698160 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16.67 Underlying: Common Stock · 31,756 shares Expires not disclosed F1 · security: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. F1 · derivative.expiration_date: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. F2 · derivative.underlying_shares: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1. Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 00:53 UTC | NextTrip, Inc. SGLB · Entity 7630 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-19-000003 · primary_doc.xml · nonDerivative · entry 1 Garofalo Frank J · CIK 0001698160 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 23:13 UTC | NextTrip, Inc. SGLB · Entity 7630 | GrantCommon Stock | 44,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-18-000062 · primary_doc.xml · nonDerivative · entry 1 Garofalo Frank J · CIK 0001698160 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Read SEC document |
| January 18, 2018 Filed Jan 23, 2018 00:03 UTC | NextTrip, Inc. SGLB · Entity 7630 | GrantCommon Stock | 5,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-18-000024 · primary_doc.xml · nonDerivative · entry 1 Garofalo Frank J · CIK 0001698160 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,814 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.